mcnamara-selfmonitoringof-2020.pdf (3.08 MB)
Self-monitoring of Blood Pressure in Patients with Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis
journal contribution
posted on 2020-03-01, 00:00 authored by J P Sheppard, K L Tucker, W J Davison, R Stevens, W Aekplakorn, H B Bosworth, A Bove, K Earle, M Godwin, B B Green, P Hebert, C Heneghan, N Hill, F D R Hobbs, I Kantola, S M Kerry, A Leiva, D J Magid, J Mant, K L Margolis, B Mckinstry, M A Mclaughlin, Kevin Mc NamaraKevin Mc Namara, S Omboni, O Ogedegbe, G Parati, J Varis, W J Verberk, B J Wakefield, R J Mcmanus© 2019 The Author(s). Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. Background: Studies have shown that self-monitoring of blood pressure (BP) is effective when combined with co-interventions, but its efficacy varies in the presence of some co-morbidities. This study examined whether self-monitoring can reduce clinic BP in patients with hypertension-related co-morbidity. Methods: A systematic review was conducted of articles published in Medline, Embase, and the Cochrane Library up to January 2018. Randomized controlled trials of self-monitoring of BP were selected and individual patient data (IPD) were requested. Contributing studies were prospectively categorized by whether they examined a low/high-intensity co-intervention. Change in BP and likelihood of uncontrolled BP at 12 months were examined according to number and type of hypertension-related co-morbidity in a one-stage IPD meta-analysis. Results: A total of 22 trials were eligible, 16 of which were able to provide IPD for the primary outcome, including 6,522 (89%) participants with follow-up data. Self-monitoring was associated with reduced clinic systolic BP compared to usual care at 12-month follow-up, regardless of the number of hypertension-related co-morbidities (-3.12 mm Hg, [95% confidence intervals -4.78, -1.46 mm Hg]; P value for interaction with number of morbidities = 0.260). Intense interventions were more effective than low-intensity interventions in patients with obesity (P < 0.001 for all outcomes), and possibly stroke (P < 0.004 for BP control outcome only), but this effect was not observed in patients with coronary heart disease, diabetes, or chronic kidney disease. Conclusions: Self-monitoring lowers BP regardless of the number of hypertension-related co-morbidities, but may only be effective in conditions such obesity or stroke when combined with high-intensity co-interventions.
History
Journal
American Journal of HypertensionVolume
33Issue
3Pagination
243 - 251Publisher
Oxford AcademicLocation
Oxford, Eng.Publisher DOI
Link to full text
ISSN
0895-7061eISSN
1941-7225Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
blood pressurecoronary heart diseasediabeteshypertensionobesityrandomized controlled trialstrokeScience & TechnologyLife Sciences & BiomedicinePeripheral Vascular DiseaseCardiovascular System & CardiologyPRIMARY-CARECLINICAL INERTIACONTROLLED-TRIALMANAGEMENTMULTIMORBIDITYDISEASEURBANINTERVENTIONTELEMEDICINEPREVALENCE
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC